Electromagnetic High-Frequency Chest Wall Oscillation on Pulmonary Mucus Clearance in Patients With Impaired Self-Expectoration
Recruiting now · Not applicable
Conditions studied: Sputum
In brief
This exploratory study aims to evaluate the efficacy and safety of an electromagnetic high-frequency, low-strain chest wall oscillation device for enhancing pulm
Key facts
- Study ID
- NCT07347366
- Run by
- Pusan National University Yangsan Hospital
- People needed
- 45
- Starts
- 2025-09-23
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-01-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Hospitalized patients who require sputum clearance.
- Patients who present with fever or respiratory symptoms (cough, sputum) and, after confirmation of findings on imaging studies, are judged by the clinician to require sputum clearance.
- Adult patients (≥ 18 years) who have signed the informed consent form, or patients for whom consent has been obtained from a legally authorized representative
You may not qualify if…
- Patients with severe pneumonia requiring intensive care unit (ICU) treatment.
- Patients with major pulmonary diseases other than pneumonia, such as active tuberculosis or lung cancer.
- Patients with severe respiratory failure (PaO₂/FiO₂ ≤ 200 mmHg).
- Patients with hemodynamically unstable cardiovascular disease (myocardial infarction within the past 3 months, or heart failure of NYHA class 3 or higher).
- Patients hospitalized for head and neck trauma whose surgical site has not yet healed.
- Patients with serious cardiac arrhythmias or hemodynamic instability.
- Patients who have had pneumothorax or massive hemoptysis within the past 6 months, or who currently have hemoptysis.
- Patients who have undergone spinal surgery within the past 6 months or who have acute spinal injury.
- Patients with osteoporosis.
- Patients with bronchopleural fistula.
- Pregnant or breastfeeding women.
- Patients diagnosed with cervical disc disease.
- Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months (however, patients enrolled in chronic lung disease cohort studies such as asthma or COPD are allowed).
- Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study
Where it is running
- Rehab lab, Pusan National University Yangsan Hospital — Yangsan, Gyeongsangnam-do, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.